The Centre For Surgical Invention and Innovation
The Centre for Surgical Invention and Innovation (CSii) is a National Centre of Excellence research accelerator committed to enhancing the quality and access to healthcare for all Canadians through the development and commercialization of innovative medical robotic technologies and novel techniques. CSii is leveraging Canadian expertise in minimal access surgery and space technology to build a legacy industry that will create high tech jobs, strengthen the economy and create better medical outcomes.
IGAR in the News
Canadian Space Agency http://www.cbc.ca/player/News/TV%20Shows/The%20National/ID/2540128021/
CBC's The National, Remarkable Canadarm, "Technology is being deployed for Breast Cancer Surgery" http://www.asc-csa.gc.ca/eng/search/video/watch.asp?v=1_vfb60ac6
Hamilton's CHCH TV, "October means Breast Cancer Awareness Month" http://www.chch.com/october-means-breast-cancer-awareness-month/
http://www.cbc.ca/player/News/TV%20Shows/The%20National/ID/2540128021/ http://www.cbc.ca/player/News/TV%20Shows/The%20National/ID/2540128021/ http://www.cbc.ca/player/News/TV%20Shows/The%20National/ID/2540128021/
Meet Geralyn Lucas the author of "Why I Wore Lipstick to My Mastectomy" and "Then Came Life"!
Geralyn Lucas was only 27 when she was diagnosed with breast cancer. Shaking the foundations of her world, she was faced with the harrowing decision of whether or not to undergo a mastectomy. She shares her incredible journey in her memoir, Why I Wore Lipstick: To My Mastectomy.
Having been diagnosed at an early age, Lucas thought it was important to share her story with others to help dispel the myth that breast cancer discriminates by age. Filled with courage, humour, and inspirational candour, Why I Wore Lipstick: To My Mastectomy details Lucas’ internal struggle and soul searching to rediscover her "inner cleavage" after losing a key female-defining characteristic and feel sexy and whole once again.
IGAR Breast System: MRI Breast Biopsy and Ablation
The CSii Image Guided Automatic Robot (IGAR) is designed for use in the early detection and treatment of breast cancer. With regulatory clearance the first IGAR robotic system will have four key product features; biopsy, ablation treatment, tele-operation, and seed placement/insertion.
The system is designed to offer one stop diagnosis and treatment for patients with high risk of breast cancer.